SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Adia Med Reports No Serious Adverse Events in First Pediatric Autism Study Cohort

Adia Med reported no serious adverse events in the study’s first cohort; enrollment continues.

ADIA

Related stories